Sign In

Co-Occurring Conditions.

HIV Question Bank

Opportunistic Infections: PreventionQuestion 13/15

Questions in Topic

A 40-year-old cisgender man with HIV and a baseline CD4 count of 45 cells/mm3 was started on antiretroviral therapy and Pneumocystis pneumonia prophylaxis 3 months ago. He continues to take trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis, and at the 3-month follow-up medical visit, the HIV RNA is undetectable. He continues to take trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis.

Which one of the following would be an indication for stopping primary Pneumocystis pneumonia prophylaxis in an individual with HIV who has responded to antiretroviral therapy?

Prev  Skip

Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Question Last Updated
September 28th, 2023

Steps to Acquire CE for this Question Bank Topic:

1

Answer

Answer all questions
2

Score 80%+

Answer correctly
3

Claim CE

Choose CNE or CME
4

Give Feedback

Complete survey
5

Print Certificate

Obtain proof of CE

This question requires improvement because:


Comment further on how to improve this question or summary:



Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.